相关实验视频

Updated: Jan 8, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

静脉偏头痛与仅偏头痛:综合转录组临床分析揭示了针对性治疗的共享炎症和分离的代谢途径

Ning An^1,2, YingYing Zhang³, XinMing Rang¹

¹Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, No.148 Baojian Road Street, Nangang District, Harbin, 150000, Heilongjiang, China.

European journal of medical research

|December 11, 2025

概括

静脉偏头痛 (VM) 和仅偏头痛 (MO) 分享炎症和代谢途径,IL-17信号在VM中更活跃. CXCL8是一种常见的生物标志物,像NSAIDs这样的药物可能有助于治疗这两种疾病.

科学领域:

神经科学是一个神经科学.
基因组学就是基因组学.
药理学药理学是指药理学的学科.

背景情况:

静脉偏头痛 (VM) 和仅偏头痛 (MO) 的发病因子尚不清楚.
了解它们的相似之处和差异对于有效治疗至关重要.
这项研究整合了临床和转录基因数据,以阐明共同和独特的特征.

研究的目的:

探索VM和MO的病原和临床表现.
为了确定VM和MO之间的共享和独特的分子路径.
预测VM和MO的潜在治疗药物.

主要方法:

从VM,MO和健康对照 (HC) 进行外周血液单核细胞 (PBMC) 的转录组测序.
不同基因表达分析 (DEseq2) 和共同表达分析.
路径丰富,枢纽基因查和药物预测 (DGIdb,药物银行,临床试验).

主要成果:

与HC相比,VM和MO患者的焦虑,抑郁和睡眠障碍增加.
脑膜炎患者表现出更高的头痛频率和前庭功能障碍.
转录组分析揭示了不同的途径激活:中性粒细胞激活和胆固醇代谢在MO,和IL-17信号,信号和雌激素途径在VM. 鉴定出CXCL8是一种常见的生物标志物.

结论:

VM和MO共享重叠的临床和致病特征,包括炎症和代谢失调.
CXCL8是一种共享的生物标志物,潜在的治疗方法包括NSAID,维生素A和维拉帕米尔.
在VM中增强的炎症表明它可能是MO的高级阶段,强调了早期干预的必要性.

关键词:

在CXCL8中,CXCL8是CXCL8.临床分析临床分析只有偏头痛只有偏头痛无抗炎药 (NSAIDs) 是一种无抗炎药.周围血液中的单核细胞.文字转录学 (Transcriptomics) 是一个学科.静脉导管偏头痛是一种偏头痛.

更多相关视频

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

Published on: June 13, 2011

A Unified Methodological Framework for Vestibular Schwannoma Research

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...